Amoéba Revenue
Biotechnology Research • 
Chassieu, Auvergne-Rhône-Alpes, France • 21-50 Employees
Amoéba revenue & valuation
| Annual revenue | $2,994,425 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Key Contact at Amoéba
Jean-Baptiste Eberst
Regulatory Affairs Director
Company overview
| Headquarters | 38 avenue des Frères Montgolfier, CHASSIEU, Rhône Alpes 69680, FR |
| Phone number | +33426691600 |
| Websites | |
| NAICS | 541714 |
| SIC | 287 |
| Keywords | Sciences, Water Treatment, Agriculture, Legionella, Sustainable Solutions, Greentech, Biofilm, Plant Protection, Cooling Towers, Biological Biocide, Pathogenic Bacteria, Mildew, Biocontrol, Pathogens, Biosolutions, Key Ressources |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
Amoéba Email Formats
Amoéba uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@amoeba-nature.com), used 58.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@amoeba-nature.com | 62.5% |
{first name}.{last name} | john.doe@amoeba-nature.com | 37.5% |
About Amoéba
Founded in 2010, Amoéba is an innovative industrial greentech specialised in the treatment of microbiological risk of natural resources. Our biosolutions are based on a unique micro-organism, the amoeba Willaertia magna C2c Maky. Thanks to our scientific, industrial and commercial know-how, we are able to provide biological alternatives for different applications and industries. 𝙊𝙐𝙍 𝙎𝙊𝙇𝙐𝙏𝙄𝙊𝙉𝙎 💄 Cosmetics : Our latest innovation offers anti-aging and UV protection properties. In October 2023, in vitro studies showed that this lysate stimulates cellular functions, activates wound healing genes, promotes hyaluronic acid synthesis, and enhances anti-infective immunity. These benefits were confirmed in a spring 2024 clinical study, with statistically significant results. Amoéba has successfully registered this ingredient on the INCI list, facilitating its commercialization and establishing it as a key player in innovative skincare solutions. 🌱 Biocontrol "AXPERA": Our second technology enables plant protection in agriculture and is based on the antifungal properties of the amoeba in its lysed (non-living) form. In 2022, the US Environmental Protection Agency (US EPA) has granted approval for the use of our solution in agriculture in the USA. In the same year, Austria issued a positive recommendation for the approval of our active substance in Europe. With this innovation, Amoéba contributes to an efficient, secure and more virtuous biological agriculture. 💧 Biocide "BIOMEBA": This historical application, initiated at the foundation of the company, enables the treatment of water in cooling towers and uses the amoeba Willaertia magna C2c Maky in its living form. In 2022, the US EPA has approved the use of our active substance in closed cooling systems in the USA, making our solution the first biological biocide approved for global industrial water treatment. Youtube 👉 @AmoebaNature X 👉 @AmoebaNature
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Amoéba has 15 employees across 8 departments.
Departments
Number of employees
Funding Data
Amoéba has never raised funding before.
Amoéba Tech Stack
Discover the technologies and tools that power Amoéba's digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
JavaScript libraries
Analytics
Analytics
Maps
JavaScript libraries
CDN
Web servers
Advertising
Font scripts
JavaScript libraries
Singapore
Italy
Australia
United States
United Kingdom
BelgiumFrequently asked questions
4.8
40,000 users
